Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
General Counsel and CCO
-
Stock Symbol
-
ATHA on Nasdaq
Mark Worthington - trading volume in the past year for Athira Pharma, Inc.
Holdings reported by Mark Worthington for Athira Pharma, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Restricted Stock Units |
110K |
$62.3K |
$0.57 |
Oct 1, 2024 |
Direct |
Common Stock |
|
| Common Stock |
51.9K |
$29.4K |
$0.57 |
Sep 5, 2024 |
Direct |
|
|
| Stock Option (Right to Buy) |
110K |
|
|
Oct 1, 2024 |
Direct |
Common Stock |
|
Transactions reported by Mark Worthington for Athira Pharma, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.